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Abstract 
BACKGROUND: Dengue infection is one of the problems in the national health sector in Indonesia because the 
incidence and mortality in Indonesia due to dengue infection is still very high. In 2005 Indonesia became the 
highest contributor to dengue infection in Southeast Asia (53%) with 95.270 people and 1.298 deaths. 
AIM: This study aims to analyse differences in angiopoietin-2 levels in dengue hemorrhagic fever (DHF) with and 
without shock. 
METHODS: This study was a consecutive sampling design with the research subject was obtained based on the 
order of admission to the hospital — the serum Angiopoietin-2 levels using the ELISA method. The statistical test 
used is the independent t-test. The value of p < 0.05 was said to be statistically significant. 
RESULT: The result showed that the mean of Angiopoietin-2 levels in DHF patients with shock was higher than in 
DHF (p < 0.05). 
CONCLUSION: This study concluded that there was a difference in the average level of Angiopoietin-2 among 
DHF patients with shock compared to without shock. 
 
 
 
 
 
 
 
 
Introduction 
 
Dengue infection is one of the problems in the 
national health sector in Indonesia because the 
incidence and mortality in Indonesia due to dengue 
infection is still very high. In 2005 Indonesia became 
the highest contributor to dengue infection in 
Southeast Asia (53%) with a total of 95.270 people 
and 1.298 deaths [1]. Manifestations of bleeding, 
enlargement of the liver and increase in SGOT and 
SGPT were significantly more common in dengue 
shock syndrome (DSS) than in the DHF group [2], [3].  
In dengue infection, the liver is also involved. 
Liver cell damage, in addition to the inflammatory 
process and the formation of antigen-antibody 
complexes, also because of the process of dengue 
infection. Infected hepatocytes increase the activity of 
SGOT and SGPT, release VEGF and reduce the 
synthesis of clotting factors [4], [5], [6]. Hepatomegaly 
in dengue infection results from the direct influence of 
the dengue virus on the liver. Data from previous 
studies also show that hepatomegaly plays an 
important role as a risk factor for severe dengue virus 
infection [7]. Angiopoietin-1 and Angiopoietin-2 have 
functions in maintaining vascular function and 
integrity. Angiopoietin-1 is reported to not only play a 
role in blood vessel stabilisation during angiogenesis 
but also plays a role in inhibiting vascular permeability 
and has anti-inflammatory effects [8]. m-RNA 
molecules Ang-1 expressed in per endothelial cells 
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play a role in maintaining blood vessel stability, 
inhibiting plasma leakage, suppresses the expression 
of inflammatory genes and prevents recruitment and 
migration of leukocytes. Unlike the case of Ang-1, 
Ang-2 which is selectively expressed in endothelial 
cells when binding to the Tie 2 receptor will result in 
signalling disorders of Ang-1 / Tie 2 resulting in 
impaired vascular permeability [9], [10]. 
This study aims to analyse differences in 
angiopoietin-2 levels in dengue hemorrhagic fever 
with and without shock. 
 
 
Materials and Methods 
 
This study was an observational study with a 
comparative cross-sectional design. The angiopoietin-
2 examination was carried out in the Biomedical 
Laboratory, Faculty of Medicine, Andalas University, 
Padang.  
 
Study Population 
The study population was patients with 
dengue virus infection (DHF and DSS) who were 
hospitalised at Dr M. Djamil Central General Hospital, 
according to WHO 2011 criteria [11]. Subjects were 
part of the population that met the inclusion and 
exclusion criteria. The inclusion criteria were patients 
with dengue hemorrhagic fever who had received 
informed consent from parents to participate in the 
study with the age of 1-15 years. Exclusion criteria 
were patients suffering from other viral or bacterial 
infections based on clinical and laboratory 
examinations, receiving corticosteroid therapy, 
malnutrition and obesity. 
 
Examination of Angiopoietin-2 Levels  
Blood samples ± 2-3 cc (which is checked in 
the critical phase) that were inserted into the serum 
tube were sent to the Biomedical Laboratory, Faculty 
of Medicine, Andalas University using media transport 
at 4°C. Samples must be stored at freezing 
temperature if not checked directly after taking. 
Provide 8 strips for inspection. Dissolve serum and 
plasma with the Standard Diluent Buffer ratio 1:10. 
Then, add 25 ul Incubation Buffer to each sample. 
After that, add 100 ul Standard Diluent Buffer to the 
standard and add 100 ul standard, controls, or sample 
to the appropriate microtiter tube. Pipette a solution of 
50 ul biotinylated Hu Ang-2 Biotin Conjugate into each 
reagent plate. Mix for 30 seconds. Cover the plate 
with a cover plate and incubate for 2 hours at the 
temperature. Pull or pour the solution from the plate 
and separate the solution, and then wash 4 times 
(according to washing instructions). After that, add 
100 ul HRP Streptavidin solutions for each sample 
except empty chromagen (according to instructions for 
reagent preparation and storage). Cover the plate with 
a cover plate and incubate for 30 minutes at room 
temperature. Pull or pour the solution from the plate 
and separate the solution and wash 4 times 
(according to washing instructions). Then, add 100% 
stabilised chromogen in each case. The solution will 
turn blue. Incubate for 30 minutes at ambient room 
temperature and add 100 ul stop solution into each 
sample. Mix slowly. The solution will change colour to 
yellow. Then, read the absorbance at 450 nm on the 
readromagen device. The plot of results obtained into 
the standard. 
 
Statistical analysis 
Bivariate analysis was performed to see the 
difference in mean Angiopoietin-2 in DHF patients 
with shock and without shock. First, the data are 
analyzed using normality test to determine the 
normality of the data using the Shapiro Wilk test (n < 
50), then followed by bivariate analysis, if the data is 
normally distributed then the analysis is done using 
the dependent test t-test, but if it is known to be not 
normally distributed then Mann-Whitney test was done 
with confident interval (CI) 95% and α = 0.05. The 
conclusion of the test results if the value of p ≤ 0.05 
then H0 is rejected, meaning that there is a difference 
in the mean between the independent variables and 
the dependent variable. 
 
Research Ethics 
This study was already passed the ethics 
clearance and has been approved by the Ethics 
Committee of the Faculty of Medicine, Andalas 
University, Padang. 
 
 
Results 
 
The difference in the results of Ang-2 
examination between dengue sufferers with shock 
compared to those without shock can be seen as 
follows. 
Table 1: Differences in the results of Ang-2 examination 
between dengue sufferers with shock compared to without 
shock 
 
Variable 
DHF  
p-value DSS (n = 62) mean ± SD DHF (n = 48) mean ± SD 
Ang-2 (pg/ml) 739.66 ± 55.21 497.90 ± 220.68 0.036* 
 
Table 1 showed that the average level of Ang-
2 in DHF patients with shock 739.66 ± 55.21 pg/ml 
while DHF 49790 ± 220.68 pg/ml. The results of 
statistical tests showed that there were differences in 
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the mean levels of Ang-2 among DHF patients with 
shock compared to those without shock (p < 0.05). 
 
The cut-off point for Ang-2 levels as a 
 predictor of dengue sufferers with shock 
The cut-off point of Ang-2 levels as a predictor 
of dengue patients with shock is shown in Figure 1. 
 
Figure 1: Point cut-off of Ang-2 levels as a predictor of DHF patients 
with shock 
 
Figure 1 showed that the optimal cut-off 
points on the intersection of sensitivity and specificity 
lines to determine the cut-off point of Ang-2 levels as 
a predictor of DHF patients with shock is between 
point 48. The cut-off point of Ang-2 levels as a 
predictor of DHF patients with shock can be explained 
as follows subjects experienced DSS if the level of 
Ang-2 ≥ 427.56 pg/ml and subjects experience DHF if 
the level of Ang-2 < 427.56 pg/ml. 
The cut-off point of the sensitivity of Ang-2 
levels was 56.4%, and specificity was 58.3%. 
Accuracy of cut-off point Ang-2 levels as predictors of 
dengue patients with shock is shown in Figure 2 
below. 
 
Figure 2: Accuracy of Cut-off point Ang-2 levels as predictors of 
DHF patients with shock 
Based on the receiver operating curve 
analysis (ROC) it is known that it has an area under 
the curve (AUC) of 63.4%, which means that the cut-
off points of Ang-2 which is ≥ 427.56 pg/ml have good 
accuracy in predicting DSS events. 
 
 
Discussion 
 
The difference in the results of Ang-2 
 examination between dengue sufferers 
 with shock compared to without shock 
Haematological parameters are considered as 
potential predictors, one of which is Angiopoietin. This 
study obtained Ang-2 levels of DHF patients with 
bigger shock than without shock (p < 0.05). This 
indicates that the higher the level of Ang-2, the more 
severe the disease due to dengue virus infection. The 
main complications of dengue infection mainly affect 
the vascular system and include plasma leakage, 
which will cause hypovolemic shock and potentially 
continue to become DSS. Angiopoietin can be 
considered a potential predictor for DSS in patients 
suffering from dengue infection. This is by the 
research conducted by Rampengan et al., (2015) who 
found that an increase in Ang-2 levels could trigger 
blood vessel instability, causing an increase in 
vascular permeability and plasma leakage. In this 
study, we found an increase in Ang-2 levels in DSS 
patients compared to DHF patients and dengue fever 
[12]. 
The mechanism for increasing Ang-2 levels 
and plasma leakage is a complex cascade. Binding of 
Ang-1 with the Tie-2 receptor via the 
phosphatidylinositol-3-kinase (PI3K) Akt pathway will 
cause blood vessel stability by recruiting pericytes into 
new blood vessels and maintaining intercellular 
contact. Ang-1 also has anti-inflammatory properties 
by regulating surface molecular adhesion. The binding 
of Ang-2 to the Tie-2 receptor can inhibit Ang-1 
signalling to Tie-2 and increase blood vessel instability 
[13]. Mitchell et al. (2012) also found that DSS and 
DHF patients also had higher serum Ang-2 levels at 
baseline. Treatment compared to home care and 
compared to the control group. Release of Ang-2 from 
WPB is caused by activation of endothelial cells by 
proinflammatory cytokines, direct interaction of the 
virus with endothelial cells, the release of mast cell 
products and procoagulant factors such as thrombin 
[14]. 
Literature that has written normal levels of 
Ang-2 in children as long as the knowledge of 
researchers has not yet existed. The study by 
Rampengan et al., (2015) obtained the highest Ang-2 
level on DSS compared to DHF and dengue fever with 
a result of 2,486.21 pg/dl in dengue fever, 3,194.95 
pg/dl in DHF and 4,005.32 pg/dl on DSS. In the 
research conducted by researchers concluded that if 
the level of Ang-2 ≥ 427.56 pg/ml, then the subject will 
experience DSS (12). 
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Increased levels of Ang-2 are also associated 
with death in sepsis. In a study by David et al. (2012), 
it was found that the concentration of Ang-2 has been 
reported as a predictor of mortality in critically ill 
patients. Ang-2 cut-off value of 2.86 ng/mL predicts 
the development of severe sepsis with a sensitivity of 
75% and specificity of 56%, the cut-off value of Ang-2 
3.56 ng/mL predicts the development of septic shock 
with a sensitivity of 73% and specificity 68%, and the 
Ang-2 cut-off value of 5.1 ng/mL predicted mortality 
with 80% sensitivity and 76% specificity. This 
research is important because it can estimate the 
level of Ang-2 can be used as a biomarker in clinical 
practice so that it can be used in clinical decision-
making regarding prognosis [15]. The cut-off point 
illustrates the accuracy in predicting DSS events. The 
cut-off point value is taken from the optimal 
intersection point of the sensitivity and specificity line 
intersections used in predicting the occurrence of 
shock in DHF patients.  
This study concluded that there was a 
difference in the average level of Angiopoietin-2 
among DHF patients with shock compared to without 
shock. 
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